EVIS EXERA III - cocs | congress organisation c. schäfer

EndosCopY LIVE • congress languages english/german 

simultaneous translation English/German/Russian 

November 1 and 2, 2013 

EVIS EXERA III 

Advancing the Art of Endoscopy. 

In the pursuit of the perfect endoscopy system, Olympus introduces EVIS EXERA III 

as the next milestone towards improved clinical outcomes. 

For more information, please visit www.olympus-europa.com/EXERA3 

Congress Center Hamburg 

President: Friedrich Hagenmüller 

Thomas Rösch 

Siegbert Faiss 

Postbox 10 49 08, 20034 Hamburg, Germany | Tel. +49 40 23773-0 | www.olympus-europa.com 

www.endoclubnord.com

table of Contents 

Die weltweit am häufigsten verabreichte Marke in der 

Darmvorbereitung 1 gibt es mit Zitronen- und Orangengeschmack. 

ENDOCLUBNORD 2013 

4L Wirksamkeit 

2L Compliance * 

Foreword 5 

Program 6 

Experts 9 

General Information 15 

Registration 16 

Sponsors 17 

Hotel Reservation 19 

General Information 21 

Arrival by Deutsche Bahn (German Railway) 22 

Arrival 23 

Public Transportation – HVV-Map 25 

City Map 27 

Registration Form 29 

1 IMS Health 

* Wir empfehlen zusätzlich die Einnahme mindestens eines weiteren Liters frei gewählter, klarer Flüssigkeit. 

MOVIPREP ® /MOVIPREP ® ORANGE and NORGINE are registered trademarks of the Norgine group of companies. 

MOVIPREP ® /MOVIPREP ® ORANGE, Pulver zur Herstellung einer Lösung zum Einnehmen. Zusammensetzung: Beutel A enthält: Macrogol 3350 100 g, Natriumsulfat 

7,5 g, Natriumchlorid 2,691 g,Kaliumchlorid 1,015 g; Beutel B enthält: Ascorbinsäure 4,7 g, Natriumascorbat 5,9 g. Hilfsstoffe MOVIPREP ® : Aspartam, 

Acesulfam-Kalium, Zitronenaroma. Hilfsstoffe MOVIPREP ® ORANGE: Aspartam, Acesulfam-Kalium, Orangenaroma. Anwendungsgebiete: Zur Darmvorbereitung 

vor klinischen Maßnahmen, die einen sauberen Darm erfordern, z.B. endoskopische oder radiologische Untersuchungen des Darms. Gegenanzeigen: Gastrointestinale 

Obstruktion oder Perforation, Störungen der Magenentleerung, Ileus, Phenylketonurie, Glukose-6-Phosphatdehydrogenase-Mangel, Überempfi ndlichkeit gegen die 

Wirkstoffe oder die sonstigen Bestandteile, toxisches Megakolon als Komplikation schwerer entzündlicher Darmerkrankungen. MOVIPREP ® /MOVIPREP ® 

ORANGE 

darf nicht bei bewusstlosen Patienten angewendet werden. Nebenwirkungen: Sehr häufi g: Abdominalschmerz, Übelkeit, abdominale Aufblähung, Analreizungen, 

Unwohlsein. Häufi g: Schlafstörungen, Schwindel, Kopfschmerzen, Erbrechen, Dyspepsie, Rigor, Durst, Hunger. Gelegentlich: Dysphagie, Leberfunktionstests anormal, 

Unbehagen. Nicht bekannt: Anaphylaxie, Krampfanfälle im Rahmen einer ausgeprägten Hyponatriämie, vorübergehender Anstieg des Blutdrucks, Flatulenz, 

Brechreiz, Pruritus, Urticaria, Hautausschlag, Elektrolytverschiebungen einschließlich Bikarbonatkonzentration im Blut vermindert, Hyper- und Hypocalciämie, 

Phosphatkonzentration im Blut vermindert, Hypokaliämie und Hyponatriämie (die beiden letztgenannten Störungen treten häufi ger bei Patienten 

auf, die gleichzeitig Medikamente einnehmen, die einen Einfl uss auf die Niere haben, wie z.B. ACE-Inhibitoren und Diuretika) sowie Änderungen 

der Chloridkonzentration im Blut. Handelsformen: Eine Anwendung besteht aus 2 Btl. A und 2 Btl. B. Packungsgrößen von 1 (N 1), 10, 40, 

80, 160 und 320 Packungen einer einzelnen Anwendung. Klinikpackung mit 40 einzelnen Anwendungen. Apothekenpfl ichtig. Stand 07/2012 

www.moviprep.de 

Norgine GmbH • Postfach 1840 • D-35041 Marburg • www.norgine.de • e-mail : info@norgine.de 

Distribution supported by Olympus Europa Holding GmbH. 

2 3

ForEword 

Natriumpicosulfat + Magnesiumcitrat 

Prof. Dr. Thomas Rösch Prof. Dr. Friedrich Hagenmüller PD Dr. Siegbert Faiss 

Zur Darmreinigung vor Koloskopien oder Röntgenuntersuchungen 

Für eine gründliche 

Entleerung und Reinigung 1 

• Duales Wirkprinzip durch zwei Wirkstoffe 1 

• Hohe Patientenverträglichkeit 2 

• Schmeckt angenehm frisch nach Zitrone 3 

1 

Fachinformation CitraFleet ® Stand 12/2010 

2 

Ciáurriz A, et al. Calidad de la colonoscopia: efectividad y 

tolerancia de tres regimenes de limpieza. Poster presented at 

Semana de las Enfermedades Digestivas (SED) 11-14 de Junio, 

2011. Sevilla, Spain. 

3 

Schirin-Sokhan R., Trautwein C., MMW Fortschritte der Medizin 

Originalien 2009; 151(1): 34-38 

Innovation adds impetus to endoscopy! 

The new generation of endoscopes has such brilliant resolution that 

it makes endoscopy nearly as accurate as histology. The refinement 

of polyp classification (hyperplasia, adenoma or serrated) compels 

the endoscopist to sharpen his senses. We have learned from the 

Japanese pioneers to peel off early carcinomas of the gastrointestinal 

tract; novel and even more ingenious instruments help us do it well. 

With endoscopic myotomy for achalasia, our attention has turned to 

the submucosal space as a new therapeutic territory. Now that obesity 

is being treated surgically, the endoscopist is faced with a new type 

of post-operative anatomy, which is a particular challenge in cases of 

bile duct disease. 

From practical, down-to-earth tips for everyday routine to high-end 

endoscopy – judge for yourself! Watch the live demonstrations in 

HD quality and take part in interactive presentations. Discuss your 

impressions with elite international experts. There’s plenty to learn! 

Welcome to ENDOCLUBNORD 2013! 

CitraFleet ® Pulver zur Herstellung einer Lösung zum Einnehmen in einem Beutel. Wirkstoffe: Natriumpicosulfat, leichtes Magnesiumoxid, 

wasserfreie Citronensäure. Zusammensetzung: 1 Beutel mit 15,08 g Pulver enth. 10,0 mg Natriumpicosulfat, 3,5 g leichtes Magnesiumoxid 

und 10,97 g wasserfreie Citronensäure. Sonst. Bestandt.: Kaliumhydrogencarbonat, Saccharin-Natrium, Zitronenaroma (Zitronenaroma, 

Maltodextrin, RRR-α-Tocopherol E 307). Anwendungsgebiete: für Erwachsene ab 18 Jahren: zur Darmreinigung vor jeder 

diagnostischen Untersuchung, die nur bei einem gut gereinigten Darm sinnvoll durchgeführt werden kann (z.B. Koloskopie, Röntgen). 

Gegenanzeigen: Überempf. gg. Bestandt., dekomp. Herzinsuff., schwere Dehydrat., Hypermagnesiemie, Magenretention, Ulzerat. GIT, 

tox. Colitis, tox. Megacolon, Ileus, Übelkeit, Erbrechen, Aszitis, Appendizitis, Obstr./Perfor. GIT, Rhabdomyolyse, aktive Entzündung (Morbus 

Crohn, Colitis ulcerosa), eingeschr. Nierenfunkt. Warnhinweise: enthält 5 mmol Kalium. Nebenwirkungen: sehr häufig: Bauchschm. 

häufig: Schlafst., Kopfschm., Mundtrock., Übelkeit, Blähbauch, Analbeschw., Proktalgie, Durstgef., Müdigk., gelegentlich: Schwindel, 

orthostat. Hypot., Erbrechen, Stuhlinkont., Häufigk. n. bekannt: Anaphylaktoide Reakt., Überempf., Hyponatriämie, Epilepsie, Grandmal-Anfall, 

Konvuls., Verwirrtheitszust., Durchfall, Flatulenz, Hautausschl., Urtikaria, Pruritus, 

Purpura, Schmerzen. Apothekenpflichtig. Stand: April 2012. Zulassungsinhaber: Laboratorios 

Casen-Fleet S.L.U., Autovía de Logroño Km 13,300, 50180 UTEBO, Zaragoza, Spanien. Mitvertrieb: 

Recordati Pharma GmbH, Eberhard-Finckh-Str. 55, 89075 Ulm. 

Thomas Rösch 

Universitätsklinik 

Hamburg-Eppendorf 

Friedrich Hagenmüller 

President 2013 

Asklepios Klinik 

Altona 

Siegbert Faiss 

Asklepios Klinik 

Barmbek 

4 5

Friday, November 1, 2013 

SATURDAY, NOVEMBER 2, 2013 

9.00 – 9.15 a.m. Opening and Introduction 

President: Friedrich Hagenmüller, Hamburg 

Honorary President: Jürgen F. Riemann, Ludwigshafen 

Honorary Member: Akihiro Taguchi, Tokyo 

9.15 – 10.10 a.m. Endoscopy live, Part 1 

Live Video Broadcast from the three Hospitals: 

Asklepios Klinik Altona, Asklepios Klinik Barmbek 

and Universitätsklinik Hamburg-Eppendorf 

10.10 – 10.30 a.m. Endoscopic intervention and hepatic 

encephalopathy 

Jürgen Schölmerich, Frankfurt 

Norgine Lecture 

10.30 – 11.15 a.m. Endoscopy live, Part 2 

11.15 – 11.45 a.m. Coffee Break and visit of the Industry Exhibition 

11.45 – 12.40 p.m. Endoscopy live, Part 3 

12.40 – 01.00 p.m. Irritable Bowel Syndrome: New therapies for a 

widespread disease 

Hans-Dieter Allescher, Garmisch-Partenkirchen 

almirall Hermal Lecture 

01.00 – 02.00 p.m. Lunch Break and visit of the Industry Exhibition 


9.00 – 10.20 a.m. Friday’s Highlights 

discussion, Part 1 

Gustavo B. Baretton, Dresden 

Friedrich Hagenmüller, Hamburg 

Thomas Rösch, Hamburg 

Siegbert Faiss, Hamburg 

10.20 – 10.45 a.m. Endo Arena: 

High-end endoscopy or histology: 

What is the gold standard for the mucosa and 

submucosa? 

Andrea Tannapfel, Bochum 

Yutaka Saito, Tokyo 

Haruhiro Inoue, Yokohama 

Moderator: Jürgen F. Riemann, Ludwigshafen 

10.45 – 11.15 a.m. Coffee Break and visit of the Industry Exhibition 

11.15 – 12.00 p.m. Friday’s Highlights 

discussion, Part 2 

12.00 – 01.00 p.m. Review 2012: 

The most difficult cases from last year: 

What happened in the meantime? 

01.00 – 01.15 p.m. Closing Words and Invitation to the 

22. EndoClubNord 


02.50 – 03.10 p.m. Intestinal microbioma: Frontier on the route to 

inflammation 

Dirk Haller, Freising 

AbbVie Lecture 


04.00 – 04.30 p.m. Coffee Break and visit of the Industry Exhibition 

04.30 – 04.50 p.m. Legends of Endoscopy 

Meinhard Classen, Laszlo Safrany und Nib Soehendra 

The most important innovations and flops in endoscopy. 


6 

7

experts 

ELEVATION AND 

DISSECTION 

WITH JUST ONE 

INSTRUMENT 

Honorary president 

Prof. Dr. Jürgen F. Riemann 

Ludwigshafen, Germany 

Honorary Member 

Akihiro Taguchi 

Tokyo, Japan 

Founding president 

Prof. Dr. Nib Soehendra 

Hamburg, Germany 

ERBE HybridKnife for ESD 

The advantages 

Maximum protection against perforation 

and thermal damage of the muscularis 

Minimized risk of bleeding 

Large fluid cushion, solution can be 

replenished at any time 

Cost-effective procedure as saline solution 

is sufficient 

ESD you can trust 

Marking, elevation, incision/ 

dissection and coagulation – all 

with just a single instrument. 

Reduced risk of perforation. 

Prof. Dr. Hans-Dieter Allescher 

Klinikum Garmisch-Partenkirchen 

Garmisch-Partenkirchen, 

Germany 

Prof. Dr. Gustavo B. Baretton 

Universitätsklinikum 

Carl Gustav Carus 

Dresden, Germany 

Prof. Dr. Michael Bretthauer 

University of Oslo 

Prof. Dr. Karel Caca 

Klinikum Ludwigsburg 

Oslo, Norway 

Ludwigsburg, Germany 

Prof. Dr. Jacques Devière 

Erasme University Hospital 

Prof. Dr. Meinhard Classen 

Brüssel, Belgium 

Munich, Germany 

Further information on medical procedures 

can be found on our web site. 

Dr. Thomas Eisenbach 

Internist 

Prof. Dr. Ian M. Gralnek 

Rambam Health Care Campus 

ERBE Elektromedizin GmbH | Germany | Phone +49 7071 755-0 | www.erbe-med.com 

Leverkusen, Germany 

Haifa, Israel 

6 9

Liver 

Once daily 

in collagenous colitis 

Stomach 

Budenofalk ® 9mg 

experts 

Ascending colon 

Duodenum 

Transverse colon 

B 

Large bowel 

Collagenous 

colitis 

PD Dr. Dirk Hartmann 

Sana Klinikum Lichtenberg 

Oskar-Ziethen-Krankenhaus 

Berlin, Germany 

Prof. Dr. Dirk Haller 

TU München Wissenschaftszentrum 

Weihenstephan 

Freising, Germany 

Descending colon 

Collagenous 

colitis 

B 

Terminal ileum 

Intestine 

Jejunum 

B 

Rita Hieber 

Klinikum Augsburg 

Augsburg, Germany 

Prof. Dr. Haruhiro Inoue 

Showa University Northern 

Yokohama Hospital 

Yokohama, Japan 

Sigmoid 

Prof. Dr. Rastislav Kunda 

Aarhus University Hospital 

Dr. Dagmar Mainz 

Praxis 

Straight to the point 

Aarhus, Denmark 

Saarlouis, Germany 

Fruity lemon flavour 

Targeted steroid efficacy 

with less side effects* 

* compared to systemic steroids (Chande et al., Cochrane Database Syst Rev. 2008; Issue 2:CD003575). 

Currently approved in Austria, Germany, Great Britain, Netherlands, Ireland and Slovakia. Other countries will follow. 

PD Dr. Oliver Mann 

Universitätsklinikum 

Hamburg-Eppendorf 


Prof. Dr. Helmut Messmann 

Klinikum Augsburg 

Augsburg, Germany 

Budenofalk ® 3mg capsules; Budenofalk ® 9mg gastro-resistant granules, Budenofalk ® Rectal Foam. Active ingredient: budesonide. Composition: 1 gastro-resistant hard capsule of 

Budenofalk ® 3mg (= hard capsule with gastro-resistant pellets) contains: active ingredient: 3 mg budesonide. One sachet of Budenofalk ® 9mg gastro-resistant granules contains: active 

ingredient: 9 mg budesonide. Other ingredients for the capsules and the granules: povidone K25, lactose monohydrate, sucrose, talc, maize starch, methacrylic acid-methyl methacrylate 

copolymer (1:1), methacrylic acid-methyl methacrylate copolymer (1:2), ammonio methacrylate copolymer (type B), ammonio methacrylate copolymer (type A) (= Eudragit L, S, RS 

and RL), triethyl citrate. Additionally capsules: titanium dioxide (E171), purified water, gelatin, erythrosine (E127), iron(II,III) oxide (E172), iron(III) oxide (E172), sodium lauryl sulfate. 

Additionally granules: lemon flavour, citric acid anhydrous, magnesium stearate, sucralose, sorbitol (E420), xanthan gum. Each actuation of Budenofalk ® Rectal Foam contains: active 

ingredient: 2 mg budesonide. Other ingredients: cetyl alcohol, cetostearyl alcohol, polysorbate 60, purified water, sodium edetate, macrogolstearylether, propylene glycol, citric acid 

monohydrate, propellant gases: butane, 2-methylpropane, propane. Indications: Budenofalk ® 3mg capsules: Mild to moderate active Crohn’s disease affecting the ileum and/or 

the ascending colon. Collagenous colitis. Autoimmune hepatitis. Budenofalk ® 9mg gastro-resistant granules: Induction of remission in patients with active collagenous colitis. 

Budenofalk ® Rectal Foam: For the treatment of active ulcerative colitis limited to the rectum and the sigmoid colon. Contraindications: Hypersensitivity to budesonide or any of the 

other ingredients. Hepatic cirrhosis. Pregnancy. Lactation. Children. Close medical supervision is required in the following diseases: septicaemia, tuberculosis, hypertension, diabetes 

mellitus, osteoporosis, peptic ulcer (gastric or duodenal), glaucoma, cataract, family history of diabetes or glaucoma. Chickenpox, herpes zoster or measles. Local infections of the 

intestine (bacteria, fungi, amoebae, viruses). Severe hepatic impairment. Late stage primary biliary cirrhosis (PBC). Additionally capsules and granules: hereditary problems of galactose 

intolerance, fructose intolerance, (the Lapp) lactase deficiency, sucrase isomaltase insufficiency, glucose galactose malabsorption. Side effects: Cushing’s syndrome: moon-face, truncal 

obesity, reduced glucose tolerance, diabetes mellitus, hypertension, sodium retention with oedema formation, increased excretion of potassium, inactivity and/or atrophy of the adrenal 

cortex, red striae, steroid acne, disturbance of sex hormone secretion (e.g. amenorrhoea, hirsutism, impotence), growth retardation in children. Glaucoma, cataract, gastric complaints, 

gastroduodenal ulcer, pancreatitis, constipation. Increased risk of infection. Muscle and joint pain, muscle weakness and twitching, osteoporosis. Aseptic necrosis of bone (femur and 

head of the humerus). Headache, pseudotumor cerebri including papillary oedema in adolescents. Depression, irritability, euphoria, manifold psychiatric effects or such as impaired 

behaviour. Allergic exanthema, petechiae, ecchymosis, delayed wound healing, contact dermatitis. Increased risk of thrombosis, 

vasculitis (withdrawal syndrome after long-term therapy). Fatigue, malaise. Additionally Rectal Foam: urinary tract infections, anaemia, 

increase in erythrocyte sedimentation rate, leukocytosis, increased appetite, insomnia, dizziness, disturbances of smell, hypertension, 

nausea, abdominal pain, dyspepsia, flatulence, paraesthesias in the abdominal region, anal fissure, aphthous stomatitis, frequent urge 

to defecate, haemorrhoids, rectal bleeding, increase in transaminases (GOT, GPT), increase in parameters of cholestasis (GGT, AP), 

acne, increased sweating, increase in amylase, change in cortisol, burning in the rectum and pain, asthenia, increase in body weight. 

Side effects typical of systemic glucocorticosteroids may occur (the risk of side effects from Budenofalk ® is generally lower). 

Interactions and dosage: see patient information leaflet. Available on prescription only. Date of information: 06/2012 www.drfalkpharma.com 

Dr. Gero Moog 

Praxis 

Kassel, Germany 

Dr. Gabriele Niemann 

HELIOS Klinikum 

Emil von Behring 


Prof. Dr. Horst Neuhaus 

Evangelisches Krankenhaus 

Düsseldorf 

Düsseldorf, Germany 

Prof. Dr. Karl-Jürgen Oldhafer 

Asklepios Klinik Barmbek 


8 11

experts 

In the fight against 

pancreatico-biliary diseases, 

you want to be 

on the cutting edge. 

Ute Pfeifer 

Evangelisches Krankenhaus 

Düsseldorf 

Düsseldorf, Germany 

Prof. Dr. Yutaka Saito 

National Cancer Center 

Hospital 

Tokyo, Japan 

Prof. Dr. Laszlo Safrany 

Marbella, Spain 

Prof. Dr. Jürgen Schölmerich 

Klinikum der Johann Wolfgang 

Goethe-Universität 

Frankfurt, Germany 

Prof. Dr. Hans-Joachim Schulz 

Sana Klinikum Lichtenberg 

Prof. Dr. Wolfgang Schwenk 

Asklepios Klinik Altona 



With the right preparation and determination, almost any challenge 

can be overcome. Cutting Edge ERCP is our shared vision with 

physicians worldwide for pushing the boundaries in treating 

pancreatico-biliary diseases. 

What does Cutting Edge ERCP mean to you? 

• A broad and constantly expanding array of treatment options 

from a company that has been developing high quality innovative 

technologies for over 30 years 

• Global research to advance clinical excellence through 

evidence-based medicine 

• Deep local support and multi-faceted education programs 

to increase the skills and confi dence of your clinical staff 

• Health economics support through reimbursement education, 

analysis and advocacy 

In the ERCP suite where tough challenges are an everyday job, 

Boston Scientifi c stands with you at the cutting edge. 

Prof. Dr. Stefan Seewald 

Klinik Hirslanden 

Zürich, Switzerland 

Prof. Dr. Andrea Tannapfel 

Ruhr-Universität Bochum 

Bochum, Germany 

PD Dr. Uwe Seitz 

Kreiskrankenhaus Bergstraße 

Heppenheim, Germany 

Prof. Dr. Naohisa Yahagi 

Keio University School of 

Medicine 

Tokyo, Japan 

© 2011 by Boston Scientific Corporation 

or its affiliates. All rights reserved. PSST 6587 

13

endoscopic ultrasound 

general information 

Merging histology and cytology 

with needle flexibility. 

Congress Presidents 

Venue 

Congress 

Organization 

Prof. Dr. Friedrich Hagenmüller 

asklepios Klinik Altona 

Prof. Dr. Thomas Rösch 

universitätsklinik Hamburg-Eppendorf 

PD Dr. Siegbert Faiss 

asklepios Klinik Barmbek 

Congress Center Hamburg - CCH 

marseiller Straße ∙ 20355 Hamburg ∙ Germany 

COCS GmbH – Congress Organisation C. Schaefer 

rosenheimer Str. 145c ∙ 81671 Munich ∙ Germany 

Phone: +49 – (0)89 – 89 06 77-0 

Fax: +49 – (0)89 – 89 06 77-77 

E-mail: sandra.reber@cocs.de ∙ www.cocs.de 

Opening Hours Thursday, October 31, 2013 4.00 p.m. – 7.00 p.m. 

Registration Desk Friday, November 1, 2013 8.00 a.m. – 6.00 p.m. 

Saturday, November 2, 2013 8.00 a.m. – 2.00 p.m. 

EchoTip ® ProCore 

HD ULTRASOUND BIOPSY NEEDLE 

The smallest and most flexible biopsy needle has arrived. 

Just recently, the new 25 gage EchoTip ProCore achieved 

an 88% first-pass diagnosis in malignant tumors.* 

See what ProCore can help you achieve. 

Cook Medical—Leading the way in EUS. 

Internet 

Simultaneous 

Translation 

Certification 

Liability 

www.endoclubnord.com 

The congress languages are German and English. 

Simultaneous translations will be provided throughout 

the congress for German, English und Russian. 

Confirmation of participation will be issued to all participants 

at the end of the congress. The congress will 

be certified internationally and by the Ärztekammer 

(General Medical Council) Hamburg. 

The congress organizer will bear no liability for loss, 

accident, damage or injury to persons or property 

irrespective of the cause. The client participates at all 

sessions, tours and events at his/her own risk. Sole 

place of jurisdiction is Munich, Germany. German law 

is applicable. 

www.cookmedical.com 

Images courtesy of Kenneth Chang, MD. *Data on file at Cook Medical. 

14 15 

© COOK 2013 ESC-WEMEAM-50414-EN-201302

REGISTRATION 

sponsors 

Registration fee payment received by Sep 30, 2013 from Oct 1, 2013 

Physician € 240,- € 280,- 

Member bng/ESGE € 200,- € 240,- 

Assistance (evidence enclosed) € 70,- € 90,- 

Nurse € 70,- € 90,- 

Student (evidence enclosed) € 70,- € 90,- 

Team Ticket: 

1 physician and 2 nurses € 350,- € 390,- 



Registration 

Mode of 

Payment 

Please register via our website www.endoclubnord.com or 

complete the enclosed registration form at the end of this 

program. The final registration date is October 25, 2013. 

After this date on-site registration only. 

On your bank transfer please indicate “ECN 2013” and 

the name of the participant and transfer funds to the 

following account: 

COCS GmbH, Munich, Germany 

Account: 39 61 31 40 

Banc code: 700 202 70 

HypoVereinsbank Munich, Germany 

IBAN: DE30 7002 0270 0039 6131 40 

SWIFT/BIC: HYVEDEMMXXX 

Please note that we do not cover any bank charges. 

The EndoClubNord is grateful for the support of its sponsors: 

Olympus Deutschland GmbH, Hamburg, Germany 

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, 

Germany 

Almirall Hermal GmbH, Reinbek, Germany 

Boston Scientific Medizintechnik GmbH, Ratingen, 

Germany 

Cook Deutschland GmbH, Mönchengladbach, 

Germany 

Covidien Deutschland GmbH, Neustadt an der 

Donau, Germany 

Congress 

Documents 

Cancellation 

For payments received before October 14, 2013 by participants 

from Germany, Austria and Switzerland the personal 

congress documents will be sent by post before the congress. 

To avoid unnecessary delays the final conference 

program and your badge holder will be available in the 

entrance hall of the CCH. 

Cancellation in writing must be received no later than 

October 14, 2013. A service fee of € 20,- will be deducted 

from the refund amount. Registration fees will not be 

refunded if cancellations are received at a later date. 

Erbe Elektromedizin GmbH, Tübingen, Germany 

Dr. Falk Pharma GmbH, Freiburg, Germany 

Ferring Arzneimittel GmbH, Kiel, Germany 

medwork GmbH, Höchstadt/Aisch, Germany 

Norgine GmbH, Marburg, Germany 

Recordati Pharma GmbH, Ulm, Germany 

Shire Deutschland GmbH, Berlin, Germany 

16 17

hotel reservation 

hotel reservation 

Room contingents have been reserved in several hotels for the period October 

31 to November 2, 2013. In accordance with room availability, participants can 

book a room until September 23, 2013 under the keyword “ENDOCLUB- 

NORD”. Please note that two other big events are taking place in Hamburg at the 

same time as the ENDOCLUBNORD and hotels will be booked out early. All prices 

stated are per night and include breakfast, VAT and service. 

Hotels 

Radisson Blu Hotel Hamburg 

Connected with the CCH 

Reservations only until 

August 29, 2013. 

Renaissance Hotel Hamburg 

approx. 8 minutes walking distance 

to the CCH 

Hotel am Dammtor 

approx. 5 minutes walking 

distance to the CCH 

Address/Fee 

Marseiller Str. 2, 20355 Hamburg 

Phone: +49 (0)40 - 35 02 0 

Fax: +49 (0)40 - 35 02 3510 

E-mail: reservations.hamburg@radissonblu.com 

www.radissonblu.com/hotel-hamburg 

Single room € 190,- 

Double room € 210,- 

Große Bleichen, 20354 Hamburg, Germany 

Phone: +49 (0)40 - 35051699 

Fax: +49 (0)40 - 35051822 

E-mail: reservations.hamburg@marriotthotels.com 

www.renaissance-hamburg.com 



Schlüterstr. 2, 20146 Hamburg, Germany 

Phone: +49 (0)40 - 4500570 

Fax: +49 (0)40 - 4106300 

E-mail: buchen@hotel-am-dammtor.de 

www.hotel-am-dammtor.de 


Hotels 

Hotel Baseler Hof 



Holiday Inn Express – 

Hamburg City Centre 

approx. 8 minutes walking distance 

to station Landwehr, then 9 minutes 

travel time to the CCH 

Hotel Bellmoor 



Address/Fee 

Esplanade 11, 20354 Hamburg, Germany 

Phone: +49 (0)40 - 359060 

Fax: +49 (0)40 - 343777 

E-mail: reservierung@baselerhof.de 

www.baselerhof.de 

31.10.2013: Single room € 115,- 


01.11.2013: Single room € 125,- 


Lübecker Str. 101-109, 22087 Hamburg, Germany 

Phone: +49 (0)40 - 7344510 

Fax: +49 (0)40 - 734451100 

E-mail: hamburg@fmhos.com 

www.hiexpress.com 

31.10.2013: Single room € 89,- 


01.11.2013: Single room € 99,- 


Moorweidenstr. 34, 20146 Hamburg, Germany 

Phone: +49 (0)40 - 4133110 

Fax: +49 (0)40 - 41331141 

E-mail: info@hotel-bellmoor.de 

www.hotel-bellmoor.de 



Mercure Hotel Hamburg an 

der Messe 



Schröderstiftstr. 3, 20146 Hamburg, Germany 

Phone: +49 (0)40 - 450690 

Fax: +49 (0)40 - 450691000 

E-mail: h5394@accor.com 

www.mercure.com 



18 

19

Die geschmackvolle Darmreinigung! 

general information 

Photography/ 

filming 

SMS/E-mails 

to the 

moderators 

No photography or filming during lectures or live demonstrations 

permitted. The organizers will share selected recordings 

on the website. In case you do not wish to be 

recorded please advise in advance. 

Questions or comments during the sessions can be sent 

via 

SMS: anounced on site 

E-mail: sms@luxav.de 

• Überzeugende Sauberkeit 1 durch zweifachen Wirkmechanismus 2 

• Einfache Anwendung und frischer Orangengeschmack 

• Gute Verträglichkeit, geeignet für Kinder ab 1 Jahr 2 

MAGNESIUMCITRAT + NATRIUMPICOSULFAT 

1 Love, J et al. Can J Gastroenterol 2009;23:706-710 

2 Fachinformation 

Einfach. Sauber. 

PICOPREP ® Pulver zur Herstellung einer Lösung zum Einnehmen 

Zus.: Jeder Beutel (16,1 g) enthält: Wirkstoffe: Natriumpicosulfat 10 mg, Magnesiumoxid 3,5 g, Citronensäure 12,0 g. Sonstige Bestandteile: 

Kaliumhydrogencarbonat, Saccharin-Natrium, natürliches sprühgetrockenetes Orangenaroma mit Akaziengummi, Lactose, Ascorbinsäure, 

butyliertes Hydroxyanisol,. Anw.: Für Kinder ab 1 Jahr: Zur Darmreinigung vor Röntgenuntersuchungen, endoskopischen Untersuchungen oder 

chirurgischen Eingriffen. Gegenanz.: Überempfindlichkeit gegen einen der Bestandteile des Arzneimittels, dekompensierte Herzinsuffizienz, 

Retention von Mageninhalt, gastrointestinale Ulcera, toxische Kolitis, toxisches Megakolon, Ileus, Übelkeit, Erbrechen, abdominale chir. Notfälle, 

z. B. akute Appendizitis, Obstruktion, Perforation, schwere Dehydratation, Rhabdomyolyse, Hypermagnesiämie, aktive entzündl. Darmerkrankung, 

stark eingeschränkte Nierenfunktion. Warnhinw.: 1 Btl. enthält 5 mmol Kalium, enthält Lactose. Nebenw.: Häufig: Kopfschmerzen, 

Übelkeit, Proktalgie. Gelegentlich: Anaphylaktische Reaktion, Überempfindlichkeit, Hyponatriämie, Hypokaliämie, Epilepsie, Grand-mal-Anfall, 

Krampfanfälle, Verwirrtheit, Erbrechen, aphthoide Ulcera im Ileum, Bauchschmerzen, Hautausschlag (einschl. erythematöser und makulopapulöser), 

Urtikaria, Pruritus, Purpura. Häufigkeit nicht bekannt: Diarrhoe, Stuhlinkontinenz. Apothekenpflichtig. Stand: Juni 2010 (a). 

FERRING Arzneimittel GmbH, Fabrikstraße 7, 24103 Kiel, Tel.: 0431 5852-0, Fax: 0431 5852-74, E-Mail: info-service@ferring .de 

21

ARRIVAL 

Arrival 

Special offer by Deutsche Bahn (German Railways) – 

exclusively for congress participants 

By train to the ENDOCLUBNORD from € 99,- 

Fotoquelle: DBAG 

All trains of the Deutsche Bahn can be used with this special offer, including the 

ICE. For the ICE-Sprinter and the Deutsche Bahn night train additional costs 

apply. The ticket is not valid in the public transportation system HVV (Hamburg 

Verkehrsverbund). 

The tickets are valid between October 30 and November 4, 2013. The special 

offer is bookable 6 months (without seat reservation) respectively 3 months 

(with possible seat reservation) in advance with immediate effect under the hotline 

+49 1805 - 31 11 53** - keyword: ENDOCLUBNORD 

Please be aware that these tickets cannot be combined with other special offers 

of the Deutsche Bahn. 

The price for retaining a seat is not included in above mentioned ticket prices. 

Payment can be made by your personal credit card. You can pick up your ticket 

at on of the ticket machines (Fernverkehrs-Ticketautomat=NTA) of the Deutsche 

Bahn. For identification please use your personal credit card number. 

* Deadline for booking at least 3 days in advance. With reservation for a specific train and sale as 

long as available. Conversion and refund before the 1. day of validity EUR 15,-, from the 1. day of 

validity excluded. 

** Phone charges from the power line of the “Deutsche Telekom AG” will be charged with 14 ct/min., 

the hotline is accessible from Monday to Saturday from 8.00 a.m. – 9.00 p.m.. 

Details without guarantee. 

Travel relaxed and economic to Hamburg from 

any German train station. Preserve your travel 

budget and protect the environment. 

The price for a round-trip ticket* to Hamburg, 

Germany amounts: 

2. class € 99,- 

1. class € 159,- 

No responsibility is taken for the correctness of the details. Offered by DB Vertrieb GmbH, Vertrieb Geschäftsreisen, Stephensonstraße 1, 60623 Frankfurt/Main 

by train 

by car 

parking 

by HVV 

(public transport) 

The Congress Center Hamburg is right next door to Dammtor 

InterCity rail station. For further details related to the exclusive 

German Railways offer for ENDOCLUBNORD participants 

please see previous page. 

If you come to CCH - Congress Center Hamburg by car or 

motor bike, please follow the signs to “Messe/CCH” from all 

directions. 

The CCH offers parking for € 2,- per hour and € 14,- per day. 

Dammtor station is right next to CCH, for InterCity trains 

and S-Bahn. U-Bahn stations Stephansplatz (Opera/CCH) 

and Gänsemarkt are just a short walk away, on a route that 

passes through a landscaped park and attractive streets. 

You will be entitled to use Hamburg‘s entire public transport 

system for the duration of the conference. The network 

includes buses, “S-Bahn” (overground trains) and “U-Bahn” 

(underground metro system) as well as some of the harbour 

ferries. Your name badge will be valid as your ticket. 

Please see page 25 for HVV-Map. 

22 

23

Barmbek 

Landwehr 

Station 

(BallinStadt) 

public transportation - HVV-Map 

Advanced Ablation Technology 

for Barrett‘s Esophagus 

Covidien Deutschland GmbH 

Gewerbepark 1 

D-93333 Neustadt / Donau 

Covidien Deutschland GmbH 

GI Solutions 

+49 9445 959-0 [t] 

+49 9445 959-155 [f] 

www.covidien.com 

GI Solutions 

COVIDIEN, COVIDIEN mit Logo und das 

Covidien-Logo sind in den USA und international 

eingetragene Marken der Covidien AG. 

© 2013 Covidien. 02/2013 

Richtung Neumünster 

Richtung Neumünster/Kiel 

Richtung Lübeck 

Reinfeld 

Bad Oldesloe 

Kupfermühle 

Bargteheide 

Richtung 

Schwerin/Rostock 

Büchen 

Dahlenburg 

Neetzendorf 

Göhrde 

Dauenhof 

Horst 

Alveslohe 

Ulzburg Süd 

Langeln 

Tanneneck 

Barmstedt 

Ellerau 

Ohlstedt 

Quickborn 

Barmstedt 

Brunnenstraße 

Poppenbüttel 

Norderstedt Mitte 

Ahrensburg 

Ost 

Schmalenbeck 

Kiekut 

Großhansdorf 

Wohltorf 

Aumühle 

Friedrichsruh 

Schwarzenbek 

Müssen 

Lauenburg 

Richtung 

Dannenberg 

Wendisch Evern 

Lüneburg 

Echem 

Vastorf 

Bavendorf 

Richtung Neumünster 

Rickling 

Wahlstedt 

Fahrenkrug 

Bad Segeberg 

Altengörs 

Wakendorf 

Fresenburg 

Ahrensburg 

Hoisbüttel 

Quickborn Süd 

Richtung Uelzen 

Richtung Lübeck 

Ratzeburg 

Mölln 

Voßloch 

Buchenkamp 

Wellingsbüttel 

Ahrensburg 

West 

Hasloh 

Großbereich 

Hamburg 

Merkenstraße 

Steinfurther Allee 

Mümmelmannsberg 

Schnellbahn-/Regionalverkehr 

Rapid Transit /Regional Rail 

Infos · Fahrpläne · Service 

www.hvv.de · 040-19 449 

Boostedt 

Großenaspe 

Wiemersdorf 

Bad Bramstedt 

Bad Bramstedt Kurhaus 

Lentföhrden 

Nützen 

dodenhof 

Holstentherme 

Kaltenkirchen 

Kaltenkirchen Süd 

Henstedt-Ulzburg 

Meeschensee 

Haslohfurth 

Quickborner Straße 

Friedrichsgabe 

Moorbekhalle 

(Schulzentrum Nord) 

Gartenholz 

Bokholt 

Buckhorn 

Niendorf Nord 

Hoheneichen 

Sparrieshoop 

Volksdorf 

Schippelsweg 

Bönningstedt 

Langenmoor 

Meiendorfer Weg 

Kornweg 

(Klein Borstel) 

Joachim-Mähl-Straße 

Burgwedel 

Berne 

Elmshorn 

Richtung Itzehoe/Husum 

Farmsen 

Ohlsdorf 

Richtweg 

Garstedt 

Ochsenzoll 

Kiwittsmoor 

Langenhorn Nord 

Langenhorn Markt 

Fuhlsbüttel Nord 

Fuhlsbüttel 

Klein Borstel 

Hamburg 

Airport 

Niendorf Markt 

Schnelsen 

Tornesch 

Rahlstedt 

(Flughafen) 

Trabrennbahn 

Rübenkamp 

(City Nord) 

Sengelmannstraße 

(City Nord) 

Hagendeel 

Prisdorf 

Wandsbek- 

Gartenstadt 

Hörgensweg 

Alte Wöhr 

(Stadtpark) 

Alsterdorf 

Hagenbecks Tierpark 

Pinneberg 

Alter Teichweg 

Habichtstraße 

Lattenkamp 

(Sporthalle) 

Lutterothstraße 

Eidelstedt 

Zentrum 

Thesdorf 

Tonndorf 

Straßburger Straße 

Hudtwalckerstraße 

(Stadtpark) 

Borgweg 

Sierichstraße 

Halstenbek 

Osterstraße 

Krupunder 

Elbgaustraße 

Wandsbek 

Wandsbek 

Markt 

Emilienstraße 

Dehnhaide 

Eppendorfer 

Baum 

Christuskirche 

Hamburger Straße 

Klosterstern 

Eidelstedt 

Stellingen 

Arena 

Wandsbeker 

Chaussee 

Alster 

Langenfelde 

Großbereich 

Hamburg 

Mundsburg 

Hallerstraße 

Ritterstraße 

Uhlandstraße 

Dammtor 

(Messe /CCH) 

Diebsteich 

Schlump 

Holstenstraße 

Hasselbrook 

Wartenau 

Richtung 

Cuxhaven 

Lübecker Straße 

Billstedt 

Legienstraße 

Horner Rennbahn 

Hammer 

Kirche 

Rauhes Haus 

Burgstraße 

Lohmühlenstraße 

Sternschanze 

(Messe) 

Berliner 

Tor 

Stephansplatz 

(Oper/CCH) 

Messehallen 

Altona 

Gänsemarkt 

(Oper) 

Feldstraße 

(Heiligengeistfeld) 

Othmarschen 

Hochkamp 

Blankenese 

Iserbrook 

Sülldorf 

Rissen 

Wedel 

Nord 

Bahrenfeld 

(Botanischer Garten) 

Klein Flottbek 

St. Pauli 

Hammah 

Rothenburgsort 

Stadthausbrücke 

Hoheluftbrücke 

Saarlandstraße 

Hauptbahnhof 

Jungfernstieg 

Überseequartier 

Stade 

Tiefstack 

Central 

Billwerder-Moorfleet 

Landungsbrücken 

Reeperbahn 

Königstraße 

Agathenburg 

Mönckebergstraße 

Süd 

Dollern 

Steinstraße 

Meßberg 

Rathaus 

Mittlerer Landweg 

Hammerbrook 

(City Süd) 

Rödingsmarkt 

Baumwall 

Allermöhe 

Horneburg 

Richtung 

Bremerhaven Neukloster 

Reinbek 

Nettelnburg 

Veddel 

Friedrichsberg 

Kellinghusenstraße 

Himmelpforten 

Bergedorf 

Wilhelmsburg 

ab Herbst 2013 

HafenCity 

Universität 

Apensen 

Ruschwedel 

Harsefeld 

Bargstedt 

Brest-Aspe 

Kutenholz 

Harburg 

Meckelfeld 

Maschen 

Hittfeld 

Stelle 

Klecken 

Harburg 

Rathaus 

Heimfeld 

Bardowick 

Radbruch 

Winsen 

Buchholz 

Neuwiedenthal 

Neugraben 

Fischbek 

Neu 

Wulmstorf 

Buxtehude 

Ashausen 

Nur zeitweilig/limited services Barrierefreier Zugang zu 

den Schnellbahnen 

Suerhop 

Holm-Seppensen 

Büsenbachtal 

Sprötze 

Infos zum barrierefreien 

Zugang zu den Regionalbahnen 

unter Tel. 040-19 449 

Tostedt 

Barrier-free access to the 

rapid transit trains 

Handeloh 

Haltestellen 

Schnellbahn-/Regionalverkehr 

Rapid Transit-/Regional Rail-Stations 

Großbereichsgrenze 

Greater Hamburg boundary 

nicht im HVV 

not inside HVV network 

Parken und Reisen 

park and ride 

Richtung Soltau 

Richtung Bremen 

Information on barrier-free 

access to the regional trains 

on tel 040-19 449 

Nicht alle Regionalverkehrszüge 

halten an jedem Bahnhof 

Not all regional trains stop 

at all stations 

Fernbahnhof 

Main-Line Station 

Stand: 09.12.2012 © HVV 

25

city map 

© Marcus Venzke 

© Marcus Venzke 

27

egistration 

I will participate at the ENDOCLUBNORD 2013 

payment received by Sep 30, 2013 from Oct 1, 2013 

Please cut off and send in 

a window envelope. 

Registration also at: 

www.endoclubnord.com 

Physician € 240,- € 280,- 

Member of bng € 200,- € 240,- 

Member of ESGE € 200,- € 240,- 

Assistance (evidence enclosed) € 70,- € 90,- 

Nurse € 70,- € 90,- 

Student (evidence enclosed) € 70,- € 90,- 

Team-Ticket 




Name of the nurses attending (last name, first name): 

1. 

2. 

3. 

4. 

Payment information 

Please deposit the total amount to the account indicated below: 

COCS GmbH, Munich, Germany 

HypoVereinsbank München 

Account: 39 61 31 40 · Bank code: 700 202 70 

IBAN: DE30 7002 0270 0039 6131 40 · SWIFT/BIC: HYVEDEMMXXX 

Keyword: ECN2012 and name of participant 

Please note that we do not cover any bank charges. 

The next generation 

in clip application 

24 

medwork GmbH I Medworkring 1 I 91315 Höchstadt/Aisch I Germany I Tel.: +49 (0) 91 93 / 6 39 19-0 I Fax: +49 (0) 91 93 / 6 39 19-99 I contact@medwork.com I www.medwork.com 

 

___________________________________________________ 

Date, Signature 

29

Ms. Mr. Prof. PD Dr. Dr. 

Last Name 

First Name 

Hospital/Institute/Practice 

Department 

Street 

Zip Code City 

Area Code Phone 

E-mail 

Statistics: Office-based physician Hospital-based physician 

Specialisation: Gastroenterology Surgery Internal medicine Others 

SAVE THE DATE 

ENDOCLUBNORD 


NEU 

1x täglich 

bei Reizdarmsyndrom 

mit Obstipation * 

REGISTRATION 

Register by post or online: www.endoclubnord.com 

COCS GmbH 

Congress Organisation C. Schaefer 

Rosenheimer Str. 145c 

81671 Munich 

Germany 

 

30 Stand der Information: November 2012 

27 

New Constella ® provides 

relief of key symptoms of 

Irritable Bowel Syndrome 

with Constipation (IBS-C) 

3-fach wirksam: 

• gegen abdominelle Schmerzen 1 

• gegen Blähungen 1 

• gegen Obstipation 1 

* Das genaue Anwendungsgebiet von Constella ® entnehmen 

Sie bitte der gültigen Fachinformation. 

1 Quigley EM et al. Aliment Pharmacol Ther 2013; 37: 49 – 61. 

Under licence of 

www.almirall.de 

Constella ® 290 Mikrogramm Hartkapseln. 

Verschreibungspflichtig. Zusammensetzung: Wirkstoff: Jede Kapsel enthält 290 Mikrogramm Linaclotid. Sonst. Bestandt.: Kapselinhalt: Mikrokristalline 

Cellulose, Hypromellose, Calciumchlorid-Dihydrat, Leucin. Kapselhülle: Titandioxid (E171), Gelatine, Eisen(III)-oxid (E172), Eisen(III)-hydroxidoxid 

x H 2 

O (E172). Kapseltinte: Schellack, Propylenglycol, Konzentrierte Ammoniak Lösung, Kaliumhydroxid, Titandioxid (E171), Eisen(II,III)-oxid 

(E172). Anwendungsgebiete: Zur symptomatischen Behandlung des mittelschweren bis schweren Reizdarmsyndroms mit Obstipation (RDS-O) bei 

Erwachsenen. Gegenanzeigen: Überempfindlichkeit gegen den Wirkstoff oder einen der sonstigen Bestandteile. Patienten mit bekannter oder 

vermuteter mechanischer gastrointestinaler Obstruktion. Nebenwirkungen: Sehr häufig: Durchfall. Häufig: Virale Gastroenteritis, Bauchschmerzen, 

Blähungen, Blähbauch, Schwindelgefühl. Gelegentlich: Stuhlinkontinenz, Drang zur Stuhlentleerung, Hypokaliämie, Dehydration, Appetit vermindert, 

Orthostasesyndrom. Selten: Bikarbonat im Blut erniedrigt. 

Almirall, S. A., Spanien; Örtlicher Vertreter: Almirall Hermal GmbH • D-21462 Reinbek, www.almirall.de – e-mail: info@almirall.de

EVIS EXERA III - cocs | congress organisation c. schäfer

Create successful ePaper yourself

Delete template?

Save as template?